COMMUNIQUÉ DE PRESSE publié le 23/01/2024 à 17:00, il y a 2 années 5 mois ViviHealth and Fitbit Partner to Improve the Recovery Treatment Process ViviHealth and Fitbit have joined forces to transform the behavioral health field with advanced substance abuse remote monitoring solutions. This partnership will provide predictive and prescriptive analytics to enable structured support for individuals seeking recovery. The integration of Fitbit's wearable technology and biometric data will empower individuals and equip behavioral health centers with actionable insights. The program aims to revolutionize the field by making structured recovery support more accessible and personalized. ViviHealth Fitbit Substance Abuse Remote Monitoring Predictive Analytics Prescriptive Analytics
Publié le 08/07/2026 à 20:00, il y a 11 heures 46 minutes ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 09/07/2026 à 00:00, il y a 7 heures 46 minutes Alset AI Announces Closing of Shares for Debt Transaction
Publié le 08/07/2026 à 15:25, il y a 16 heures 21 minutes Rockhaven Announces Granting of Incentive Stock Options
Publié le 08/07/2026 à 15:00, il y a 16 heures 46 minutes Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Publié le 08/07/2026 à 15:00, il y a 16 heures 46 minutes GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Publié le 09/07/2026 à 07:30, il y a 16 minutes Gabler Group Receives Order from Asian Navy for New Generation of Mission-Critical Buoyancy Control System Components
Publié le 09/07/2026 à 07:30, il y a 16 minutes Fielmann Group accelerates international sales growth in Q2/2026 and increases pace of global expansion
Publié le 09/07/2026 à 07:30, il y a 16 minutes AGRANA reports a very significant increase in EBIT in the first quarter of 2026|27
Publié le 09/07/2026 à 07:03, il y a 43 minutes EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm Receives FDA Fast Track Designation for [⁶⁸Ga]Ga-PentixaFor for the Subtyping of Primary Aldosteronism
Publié le 09/07/2026 à 07:00, il y a 46 minutes MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy